Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 8:56 pm Purchase | 2025-06-30 | 13G | Bio-Path Holdings, Inc. BPTH | Armistice Capital, LLC | 561,148 9.990% | 561,148 (New Position) | Filing History |
| 2024-11-14 3:58 pm Purchase | 2024-09-30 | 13G | CNS Pharmaceuticals, Inc. CNSP | Armistice Capital, LLC | 1,770 3.200% | 1,770 (New Position) | Filing History |
| 2024-08-02 4:11 pm Purchase | 2024-07-29 | 13D | CNS Pharmaceuticals, Inc. CNSP | Cortice Biosciences Inc. | 956 5.700% | 956 (New Position) | Filing History |
| 2024-07-02 12:34 pm Unchanged | 2024-06-27 | 13G | CNS Pharmaceuticals, Inc. CNSP | Forster Robert | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-06-25 7:19 pm Unchanged | 2024-06-17 | 13G | CNS Pharmaceuticals, Inc. CNSP | Forster Robert | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-14 2:25 pm Purchase | 2023-12-31 | 13G | CNS Pharmaceuticals, Inc. CNSP | Armistice Capital, LLC | 23 9.990% | 17 (+308.69%) | Filing History |
| 2023-08-01 5:07 pm Purchase | 2019-12-31 | 13G | CNS Pharmaceuticals, Inc. CNSP | Priebe Waldemar | 0 0.300% | 0 (New Position) | Filing History |
| 2023-02-14 12:23 pm Purchase | 2022-12-31 | 13G | CNS Pharmaceuticals, Inc. CNSP | Armistice Capital, LLC | 6 9.990% | 6 (New Position) | Filing History |